STAT3 and psoriasis: Since PPAR β/δ may act as a direct antagonist to PPARγ [23] and PPARγ activation inhibits STAT3 [24], activation of PPARγ unsurprisingly has a mild inhibitory effect on psoriasis [25], [26].